Company intelligence / Profile preview

Nautilus Biosciences Canada

Charlottetown, Prince Edward Island, Canada

Ownership: Private
Development stage: Other

Overview

Nautilus Biosciences Canada is a marine biotechnology discovery platform focused on identifying novel bioactive compounds from marine microbial biodiversity for use as active ingredients and materials in skin care, hair care, and crop care; it does not develop its own clinical-stage therapeutics but supplies actives for commercial product development by partners such as Croda.[3][4][5]

Therapeutic areas: OtherDermatology
Modalities: Small moleculeMicrobial therapy
Industry: Non-Drug Biotech

Partnerships

Croda International

Beyond the preview

Go deeper on Nautilus Biosciences Canada.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nautilus Biosciences Canada.

Explore the full profile